These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2566160)

  • 1. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
    Corrias A; Corona GB; Pelosi U; Corda R
    Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
    Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
    Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
    Scoditti S; Paladini A; Stomeo S; Toma P; Aversa C
    Arch Monaldi Mal Torace; 1987; 42(4):383-8. PubMed ID: 2908264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of the protective effect of broxaterol and salbutamol in bronchial spasm induced with an ultrasonic aerosol of distilled water].
    De Francesca F; Grembiale RD; Bova G; Pelaia G; Tranfa CM; Marsico SA
    Arch Monaldi; 1985; 40(3-4):111-22. PubMed ID: 3842058
    [No Abstract]   [Full Text] [Related]  

  • 8. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
    Rampulla C; Corsico R; Majani U; Lodola E
    Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution.
    Mannino F; Anticoli S; De Luca A; Terzano C
    Allergol Immunopathol (Madr); 1996; 24(2):70-4. PubMed ID: 8933892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
    Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
    Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
    Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective action of broxaterol in bronchial spasm induced by ultrasonic mist].
    Aversa C; Scorrano F; Scoditti S; Pancosta G; Stomeo S
    Arch Monaldi Mal Torace; 1988; 43(3):243-8. PubMed ID: 2908378
    [No Abstract]   [Full Text] [Related]  

  • 15. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
    Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
    Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand.
    Chang CL; Cooray M; Mills G; Hancox RJ
    N Z Med J; 2007 Dec; 120(1267):U2874. PubMed ID: 18157200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.
    Boner AL; De Stefano G; Niero E; Vallone G; Gaburro D
    Ann Allergy; 1987 Jan; 58(1):54-8. PubMed ID: 2948430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
    Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
    Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.